Fig. 5
From: Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France
Median Angioedema Quality of Life Questionnaire (AE-QoL) scores. aP-values refer to comparisons of the mean AE-QoL scores shown in this table. bOccurrence of attack after D0 (yes/no) was included as a covariate in this analysis to evaluate whether it had an impact on AE-QoL score change. Nonsignificant (P > 0.05). cThis domain reflects impairment in work, physical activity, and social activities [14]. D day, M month, SD standard deviation